Market cap: $220,660,855
Exchange: ASE
Sector: Electronic Technology
Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
Company Name
Senseonics Holdings Inc
Average Volume (10 days)
1,570,189
Average Volume (30 days)
2,521,176
Moving Average (50 days)
$0.5038
Moving Average (200 days)
$0.5595
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
-3.6538
Market Cap
220,660,855
Shares Outstanding
530,817,549
52-Week High Split Adjust Only
1.05
52-Week Low Split Adjust Only
0.3838
Employee Count
162
Beta
1.8883
Next Earnings Date
2024-05-07
TTM Dividend Rate Per Share
0
Past 5 days
0.04%
Past 30 days
-0.26%
Past 3 months
-0.22%
Past 6 months
-0.14%
Past year
-0.27%
Past 2 years
-0.72%
Past 5 years
-0.82%
Max % Change
-0.85%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Senseonics Holdings Inc. | SENS | n/a | n/a | n/a | n/a | n/a |
| Peer Avg | N/A | 4.09 | 4.14 | 17.5 | 4.09 | 3.87 |
| Orthofix Medical Inc | OFIX | 1.95 | 2.24 | 69.9 | 1.95 | 1.78 |
| Nevro Corp | NVRO | 14.43 | 14.31 | n/a | 14.43 | 13.71 |
| Neurometrix Inc. | NURO | n/a | n/a | n/a | n/a | n/a |